Phosphonate Compounds
US-2015051174-A1 · Feb 19, 2015 · US
Acyclic nucleoside phosphonate diesters
US9387217B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9387217-B2 |
| Application number | US-201514874027-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 2, 2015 |
| Priority date | Mar 15, 2013 |
| Publication date | Jul 12, 2016 |
| Grant date | Jul 12, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating an HPV viral infection in a host in need thereof comprising administering an effective amount of a compound of the formula: or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier. 2. The method of claim 1 , wherein the viral infection is HPV 11. 3. The method of claim 1 , wherein the viral infection is HPV 16. 4. The method of claim 1 , wherein the viral infection is HPV 18. 5. The method of claim 1 , wherein the host is a human. 6. The method of claim 2 , wherein the host is a human. 7. The method of claim 3 , wherein the host is a human. 8. The method of claim 4 , wherein the host is a human. 9. The method of claim 5 , wherein the pharmaceutically acceptable carrier is suitable for topical delivery. 10. The method of claim 6 , wherein the pharmaceutically acceptable carrier is suitable for topical delivery. 11. The method of claim 7 , wherein the pharmaceutically acceptable carrier is suitable for topical delivery. 12. The method of claim 8 , wherein the pharmaceutically acceptable carrier is suitable for topical delivery.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9387217B2 cover?
- The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
- Who is the assignee on this patent?
- Univ California
- What technology area does this patent fall under?
- Primary CPC classification C07F9/65616. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).